Skip to main content

MERGERS: AMO SR initiated the administrative proceedings in the matter of a merger of Unilabs Diagnostics AB, AeskuLab Holding, a.s. and Alpha medical, s. r. o.

Updated on:
On 24 February 2017 the Antimonopoly Office of the Slovak Republic (hereafter „the Office“) initiated the administrative proceedings in the matter of a merger which according to a notification is grounded in the acquisition of indirect exclusive control of the undertaking Unilabs Diagnostics AB, Sweden belonging to the investment portfolio of Apax Partners LLP, Great Britain over the undertakings AeskuLab Holding, a.s., the Czech Republic and Alpha medical, s. r. o., the Slovak Republic.
Sector: healthcare – laboratory diagnostics
Third parties, namely natural and legal persons may submit their comments, objections and information on notified mergers to the Office. We request the third parties to submit their comments to the Office as soon as possible following the publishing of notification what may allow the Office to deal with these comments in the first phase of assessment of notified merger with respecting the legal periods.